Seite - 87 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Conniotet al. Nanocarriers for immunecell targetingand tracking Carrillo-Conde, B., Song, E.H.,Chavez-Santoscoy,A., Phanse, Y., Ramer-Tait, A. E., Pohl,N. L., et al. (2011).Mannose-functionalized “pathogen-like” polyan- hydride nanoparticles target C-type lectin receptors on dendritic cells.Mol. Pharm.8,1877–1886.doi:10.1021/mp200213r Carpenito,C.,Milone,M.C.,Hassan,R., Simonet, J. C., Lakhal,M., Suhoski,M. M., et al. (2009). Control of large, established tumor xenografts with geneti- callyretargetedhumanTcellscontainingCD28andCD137domains.Proc.Natl. Acad.Sci.U.S.A.106,3360–3365.doi:10.1073/pnas.0813101106 Chan, K.W., Bulte, J. W., andMcMahon, M. T. (2014). Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes:physicochemicalproperties and imaging applications.Wiley Interdiscip. Rev.Nanomed.Nanobiotechnol. 6, 111–124.doi:10.1002/wnan.1246 Chapuis,F.,Rosenzwajg,M.,Yagello,M.,Ekman,M.,Biberfeld,P., andGluckman, J.C. (1997).Differentiationofhumandendritic cells frommonocytes in vitro. Eur. J. Immunol.27,431–441.doi:10.1002/eji.1830270213 Chen,M.,Ouyang,H.,Zhou,S.,Li,J.,andYe,Y.(2014a).PLGA-nanoparticlemedi- ateddeliveryofanti-OX40monoclonalantibodyenhancesanti-tumorcytotoxic Tcell responses.Cell. Immunol.287,91–99.doi:10.1016/j.cellimm.2014.01.003 Chen, Y., Gu,H., Zhang,D. S., Li, F., Liu, T., andXia,W. (2014b).Highly effec- tive inhibition of lung cancer growth andmetastasis by systemic delivery of siRNA viamultimodalmesoporous silica-based nanocarrier. Biomaterials 35, 10058–10069.doi:10.1016/j.biomaterials.2014.09.003 Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., et al. (2007). Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drugdelivery.Biomaterials28,869–876.doi:10.1016/j.biomaterials.2006.09.047 Cheong, C., Matos, I., Choi, J. H., Dandamudi, D. B., Shrestha, E., Longhi, M. P., et al. (2010).Microbial stimulation fully differentiates monocytes to DC- SIGN/CD209(+)dendriticcells forimmuneTcellareas.Cell143,416–429.doi: 10.1016/j.cell.2010.09.039 Chipman, S. D., Oldham, F. B., Pezzoni, G., and Singer, J.W. (2006). Biological andclinicalcharacterizationofpaclitaxelpoliglumex(PPX,CT-2103),amacro- molecularpolymer-drugconjugate. Int. J.Nanomedicine1,375–383. Cho,N.H.,Cheong,T.C.,Min, J.H.,Wu, J.H., Lee, S. J., Kim,D., et al. (2011). A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy.Nat.Nanotechnol.6,675–682.doi:10.1038/nnano.2011.149 Chow, E. K., and Ho, D. (2013). Cancer nanomedicine: from drug delivery to imaging.Sci.Transl.Med.5,216rv214.doi:10.1126/scitranslmed.3005872 Christian,D.A.,Cai,S.,Bowen,D.M.,Kim,Y.,Pajerowski, J.D.,andDischer,D.E. (2009).Polymersomecarriers: fromself-assembly to siRNAandprotein thera- peutics.Eur. J.Pharm.Biopharm.71,463–474.doi:10.1016/j.ejpb.2008.09.025 Colvin,E.K. (2014).Tumor-associatedmacrophagescontribute to tumorprogres- sion inovariancancer.Front.Oncol.4:137.doi:10.3389/fonc.2014.00137 Conde, J., Bao, C., Cui, D., Baptista, P. V., and Tian, F. (2014). Antibody-drug gold nanoantennaswithRaman spectroscopic fingerprints for in vivo tumour theranostics. J.Control.Release183,87–93.doi:10.1016/j.jconrel.2014.03.045 Condeelis, J., and Pollard, J. W. (2006). Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263–266. doi: 10.1016/j.cell.2006.01.007 Cornelissen, R., Lievense, L. A.,Maat, A. P.,Hendriks, R.W.,Hoogsteden,H.C., Bogers, A. J., et al. (2014). Ratio of intratumoralmacrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma. PLoS ONE 9:e106742.doi:10.1371/journal.pone.0106742 Cortez-Retamozo, V., Etzrodt, M., Newton, A., Rauch, P. J., Chudnovskiy, A., Berger, C., et al. (2012). Origins of tumor-associatedmacrophages and neu- trophils.Proc.Natl. Acad. Sci.U.S.A.109, 2491–2496. doi: 10.1073/pnas.11137 44109 Couvreur, P., Stella, B., Reddy, L.H.,Hillaireau,H., Dubernet, C., Desmaele, D., et al. (2006).Squalenoylnanomedicinesaspotential therapeutics.NanoLett.6, 2544–2548.doi:10.1021/nl061942q Cruz, L. J., Tacken, P. J., Bonetto, F., Buschow, S. I., Croes, H. J., Wijers, M., et al. (2011).Multimodal imaging of nanovaccine carriers targeted to human dendriticcells.Mol.Pharm.8,520–531.doi:10.1021/mp100356k Daldrup-Link,H.E.,Meier,R.,Rudelius,M.,Piontek,G.,Piert,M.,Metz, S., et al. (2005).Invivotrackingofgeneticallyengineered,anti-HER2/neudirectednatu- ralkillercells toHER2/neupositivemammarytumorswithmagneticresonance imaging.Eur.Radiol.15,4–13.doi:10.1007/s00330-004-2526-7 Danhier,F.,Ansorena,E., Silva, J.M.,Coco,R.,LeBreton,A., andPreat,V. (2012). PLGA-basednanoparticles: anoverviewof biomedical applications. J. Control. Release161,505–522.doi:10.1016/j.jconrel.2012.01.043 Danhier, F., Feron,O., and Preat, V. (2010). To exploit the tumormicroenviron- ment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J.Control.Release148,135–146.doi:10.1016/j.jconrel.2010.08.027 Davidson,W. F., Giese, T., and Fredrickson, T.N. (1998). Spontaneous develop- mentofplasmacytoidtumorsinmicewithdefectiveFas-Fasligandinteractions. J.Exp.Med.187,1825–1838. DeVries, I. J., Krooshoop,D. J., Scharenborg, N.M., Lesterhuis,W. J., Diepstra, J. H., VanMuijen, G. N., et al. (2003). Effectivemigration of antigen-pulsed dendritic cells to lymph nodes inmelanoma patients is determined by their maturationstate.CancerRes.63,12–17. De Vries, I. J., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., Van Krieken, J. H., Boerman, O. C., et al. (2005).Magnetic resonance tracking of dendritic cells inmelanoma patients formonitoring of cellular therapy.Nat. Biotechnol. 23, 1407–1413.doi:10.1038/nbt1154 Denardo, S. J., Denardo, G. L., Natarajan, A., Miers, L. A., Foreman, A. R., Gruettner,C., et al. (2007).Thermaldosimetrypredictiveof efficacyof 111In- ChL6 nanoparticle AMF–induced thermoablative therapy for human breast cancer inmice. J.Nucl.Med.48,437–444. Desmaele, D., Gref, R., andCouvreur, P. (2012). Squalenoylation: a generic plat- form for nanoparticular drug delivery. J. Control. Release 161, 609–618. doi: 10.1016/j.jconrel.2011.07.038 Devaraj,N.K., Keliher, E. J., Thurber,G.M.,Nahrendorf,M., andWeissleder, R. (2009).18Flabelednanoparticlesfor invivoPET-CTimaging.Bioconjug.Chem. 20,397–401.doi:10.1021/bc8004649 Dhodapkar,M.V., Dhodapkar, K.M., and Palucka, A. K. (2008). Interactions of tumor cellswithdendritic cells: balancing immunity and tolerance.CellDeath Differ.15,39–50.doi:10.1038/sj.cdd.4402247 Dilnawaz, F., Singh, A., Mohanty, C., and Sahoo, S. K. (2010). Dual drug loadedsuperparamagnetic ironoxidenanoparticles for targetedcancer therapy. Biomaterials31,3694–3706.doi:10.1016/j.biomaterials.2010.01.057 Diwan, M., Tafaghodi, M., and Samuel, J. (2002). Enhancement of immune responses by co-delivery of aCpGoligodeoxynucleotide and tetanus toxoid in biodegradablenanospheres.J.Control.Release85,247–262.doi:10.1016/S0168- 3659(02)00275-4 Dougan,M.,Li,D.,Neuberg,D.,Mihm,M.,Googe,P.,Wong,K.K., et al. (2011). A dual role for the immune response in a mouse model of inflammation- associated lungcancer. J.Clin. Invest.121,2436–2446.doi:10.1172/JCI44796 Dunn,G.P.,Bruce,A.T., Ikeda,H.,Old,L. J., andSchreiber,R.D. (2002).Cancer immunoediting: from immunosurveillance to tumor escape.Nat. Immunol. 3, 991–998.doi:10.1038/ni1102-991 Dzhagalov, I.L.,Melichar,H. J.,Ross, J.O.,Herzmark,P., andRobey,E.A. (2012). Two-photon imaging of the immune system.Curr. Protoc. Cytom.Chapter 12, Unit1226.doi:10.1002/0471142956.cy1226s60 Eerola,A.K.,Soini,Y., andPaakko,P. (2000).Ahighnumberof tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis inoperated small cell lung carcinoma.Clin.CancerRes.6, 1875–1881. Ehmann, F., Sakai-Kato, K., Duncan, R., Hernan Perez De La Ossa, D., Pita, R., Vidal, J. M., et al. (2013). Next-generation nanomedicines and nanosim- ilars: EU regulators’ initiatives relating to the development and evaluation of nanomedicines.Nanomedicine(Lond).8,849–856.doi:10.2217/nnm.13.68 Ehrlich, P. (1909). Beiträge zur Experimentellen Pathologie und Chemotherapie. Leipzig:AkademischeVerlagsgesellschaft. Engels, B., Engelhard, V. H., Sidney, J., Sette, A., Binder, D. C., Liu, R. B., et al. (2013). Relapse or eradication of cancer is predicted by peptide- major histocompatibility complex affinity. Cancer Cell 23, 516–526. doi: 10.1016/j.ccr.2013.03.018 Ercolini,A.M.,Ladle,B.H.,Manning,E.A.,Pfannenstiel,L.W.,Armstrong,T.D., Machiels, J.P.,etal. (2005).Recruitmentof latentpoolsofhigh-avidityCD8(+) T cells to the antitumor immune response. J. Exp.Med. 201, 1591–1602. doi: 10.1084/jem.20042167 Erdag, G., Schaefer, J. T., Smolkin,M. E., Deacon,D.H., Shea, S.M., Dengel, L. T., et al. (2012). Immunotype and immunohistologic characteristics of tumor- infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res. 72, 1070–1080. doi: 10.1158/0008-5472.CAN- 11-3218 Escribese, M. M., Casas, M., and Corbi, A. L. (2012). Influence of low oxygen tensions on macrophage polarization. Immunobiology 217, 1233–1240. doi: 10.1016/j.imbio.2012.07.002 Frontiers inChemistry | ChemicalEngineering November2014 |Volume2 |Article105 | 87